To determine the prevalence, correlates, and predictors of work disability (WD) in the Genetics versus ENvironment In Scleroderma Outcome Study (GENISOS). We hypothesized that WD in systemic sclerosis (SSc) is a function of demographic, clinical, and psychosocial factors. Methods: Patients enrolled in the GENISOS cohort were subdivided in 3 groups: work disabled, working, and retired or homemakers. The latter group (n ϭ 29) was excluded from further analysis. We used logistic regression analysis with a forward hierarchical variable selection strategy to investigate the independent correlates of WD at enrollment. Cox regression proportional Hazard's model with a similar variable selection strategy was utilized to determine the predictors of WD in those working at enrollment. Results: Overall, 284 patients with a mean age of 48.7 years and disease duration of 2.5 (Ϯ1.6) years were enrolled into the GENISOS cohort, consisting of 83.5% female, 46.8% white, 28.9% Hispanic, and 20.4% African American. Patients were longitudinally followed in 1438 study visits. At enrollment, 124 patients (43.7%) were work disabled, whereas 131 (46.1%) were working. Lower level of education (P Ͻ 0.001), higher Medsger Lung Severity Index (P ϭ 0.012), higher Fatigue Severity Score (P ϭ 0.008), and less social support (P Ͻ 0.001) correlated independently with WD. Of those working at baseline, 35 (26.7%) eventually developed WD. Nonwhite ethnicity (P ϭ 0.038), lower DLCO % predicted value (P ϭ 0.038), and higher Fatigue Severity Score (P ϭ 0.009) at enrollment independently predicted WD on follow-up visits. Conclusions: WD is a major problem among SSc patients and its prevalence is substantially higher than other rheumatic conditions. Demographic, clinical, and psychosocial factors correlate with WD cross-sectionally and predict WD longitudinally in these patients.
S ystemic sclerosis (SSc, scleroderma) is a chronic, multisystem, connective tissue disease of unknown etiology characterized by inflammation, vasculopathy, and widespread fibrosis of skin and internal organs (1) . It is associated with substantial morbidity and mortality (2, 3) . Advances in diagnosis and treatment have improved the prognosis of SSc in recent years (4, 5) . Nevertheless, this disease continues to have a detrimental impact on patients' personal and professional lives (6) (7) (8) (9) (10) (11) (12) .
Previous studies by the National Arthritis Data Work Group and other investigators have shown a substantial increase in the economic impact of musculoskeletal and rheumatic conditions over the last decades in the United States. This has increased from $4 billion in 1963 (13) to $353 billion in 2005 (14) , with a major proportion attributable to indirect costs of work disability (WD) and wage loss (13, 14) . WD continues to be a major burden on individuals affected from rheumatic conditions. This may become even more prominent in the future, as the working years and productivity lost due to WD will increase with the expected increase in the retirement age (15) .
WD has been extensively studied in other rheumatic conditions such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and ankylosing spondylitis (16) (17) (18) (19) (20) . Although a few studies have addressed WD and its correlates in patients with SSc in other countries (7) (8) (9) (10) (11) 21) , there are no studies investigating this issue in the United States. Moreover, there are no published prospective studies reports investigating the long-term predictors of WD in SSc patients.
In the current study, we hypothesized that WD in SSc is a function of demographic, clinical, and psychosocial factors. We investigated the prevalence of WD in a multiethnic cohort of early SSc patients and assessed the factors associated with WD, at early stages of disease. Then, we longitudinally examined the predictors of WD in the patients who were working at enrollment.
METHODS
The Genetics versus ENvironment In Scleroderma Outcome Study (GENISOS) is a multicenter prospective study of early SSc patients. It is conducted at the 3 following sites: the University of Texas Health Science Center at Houston (UTHSC-H), the University of Texas Medical Branch at Galveston (UTMB), and the University of Texas Health Science Center at San Antonio (UTHSC-SA). Study recruitment started in January 1998 and is ongoing.
Study Subjects
Details of patient selection and recruitment have been previously described (3, (22) (23) (24) (25) . Patients who fulfilled the following inclusion criteria were enrolled: (1) age Ն18 years; (2) diagnosis according to the American College of Rheumatology (formerly the American Rheumatism Association) criteria for SSc (26) ; (3) disease onset (defined as onset of the first non-Raynaud symptom) within 5 years of enrollment; and (4) defined ethnicity with all 4 grandparents from the same ethnic group. Patients who had SSc-like illnesses associated with environmental, ingested, or injected agents were excluded from the study. All 284 patients enrolled at the time of analysis were included in this study. The institutional review boards of all participating sites approved the study and written informed consent was obtained from all subjects.
Data Collection and Questionnaires
As previously described (3, (22) (23) (24) (25) , the demographic, clinical, laboratory tests, chest radiographs, pulmonary function tests, autoantibody profile, patient-reported clinical outcomes as well as behavioral, psychosocial, and functional data were obtained at the baseline visit and then on subsequent semiannual visits.
Outcome Variable
The primary outcome was the occupational status. We have annually gathered this information in a questionnaire designed according to the definitions in the Dictionary of Occupational Titles by the United States Department of Commerce (27, 28) . The questionnaire collected the employment status (working full-time or part-time, unemployed, retired, disabled, student, or homemaker), job description, and the reason of the current job status if anything other than working full-time. We categorized the patients into 3 groups (Fig. 1) . Group A included patients working full-time, part-time for reasons other than health problems, and full-time students. Full-time work was defined as working Ն40 hours per week. Group B were work-disabled individuals, including those who were early retired, unemployed, or part-time workers because of health problems. Furthermore, the third group of patients (group C) consisted of homemakers, retired, and unemployed individuals for reasons other than health problems. We excluded group C from further analysis as we could not determine whether their occupational status was attributable to SSc. 
Independent Variables
Independent variables from the following domains were investigated: demographic, clinical, patient-reported clinical, and psychosocial variables.
Demographic Information. Age at enrollment, gender, ethnicity, marital status, educational level, and smoking status were recorded. Marital status data were dichotomized as being married or in a marriage-like relationship versus being single, divorced, separated, or never married. We also dichotomized the educational level as holding an associate's degree and above versus high school diploma and below.
Clinical Manifestations. All patients were examined by the study investigators at the 3 study sites. Disease characteristics included disease type based on the extent of skin involvement (29) , duration, and antibody profile. We calculated the disease duration with 2 different methods: from the first non-Raynaud's phenomenon symptom attributable to SSc and from the first symptom attributable to SSc (Raynaud's or non-Raynaud's phenomenon symptoms). History and physical examination findings, Modified Rodnan Skin Score (MRSS) (30), Medsger Severity Index (31) , and history of corticosteroid and cyclophosphamide use were recorded. Presence of digital ulcers was determined based on the investigators' clinical assessment. SSc cardiac involvement was defined as having clinically significant arrhythmia or ejection fraction Յ40%.
As previously described (22) , all pulmonary function tests were reviewed by a pulmonologist and studies that did not fulfill the American Thoracic Society/European Respiratory Society were excluded (32, 33) . Myositis was diagnosed if the patient had proximal muscle weakness with at least 1 of the following: elevated levels of muscle enzymes, myopathic changes on electromyography, and/or a characteristic muscle biopsy. A decrease in range of motion Ͼ25% in at least 1 joint axis was defined as joint contracture. Small joint contracture was determined based on involvement of metacarpophalangeal and/or proximal interphalangeal finger joints, while large joint contracture was defined as involvement of elbow and/or knee joints. Arthritis was defined as the presence of joint swelling and tenderness on physical examination not attributable to osteoarthritis, crystalline arthropathy, or trauma. Abnormal renal function was defined as serum creatinine Ն1.5 mg/dL. Furthermore, we calculated the number of comorbid conditions in each patient based on the patients' history of cardiovascular disease, hypertension, diabetes mellitus, stroke, lung disease, malignancy, kidney disease, SLE, RA, thyroid disease, osteoarthritis, fibromyalgia, peptic ulcer disease, obesity (body mass index Ն30), depression, and other neuropsychiatric disorders.
Patient-Reported Clinical Outcomes. Pain and shortness of breath were captured on a visual analog scale ranging from 0 to 10. Higher numbers indicated more severe pain and dyspnea.
Psychosocial Variables. Six psychosocial variables were measured: fatigue, social support, illness behavior, learned helplessness, self-perceived physical and mental health, as well as functional status. Fatigue was assessed with Fatigue Severity Scale (FSS), a validated 29-item questionnaire (34) . Answers to each question were rated from 1 to 7 (no fatigue to very severe fatigue impaired function). Higher scores indicated more fatigue. Social support was evaluated by using the Interpersonal Support Evaluation List (ISEL) (35) . ISEL is a 40-item validated instrument comprising 4 scales ranging from 0 to 3 on each question and a summary measure. Higher scores indicated better social support. Coping with illness was assessed with the Illness Behavior Questionnaire (IBQ) (36) . IBQ is a 62-item instrument comprising 7 scales measuring generalized hypochondriasis, disease conviction, denial, affective disturbance, affective inhibition, psychosocial versus somatic, and irritability plus a summary measure with a range of 0 to 35. Higher IBQ scores indicate less appropriate illness behaviors. Learned helplessness was ascertained with the Arthritis Helplessness Index (AHI), a 15-item standardized questionnaire used in other chronic illnesses (37) . Higher AHI scores indicate more perceived helplessness concerning the ability of the patient to impact on their illness. We used the medical outcome study Short Form-36 (SF-36) to assess self-perceived mental and physical functioning (38) (39) (40) . The SF-36 compromised of 8 healthrelated quality-of-life measures: physical functioning, role-physical, bodily pain, general health perceptions, vitality, social functioning, and role limitations due to emotional problems and mental health were individually scored. These scores were then summarized into the mental component (MCS) and physical component (PCS) summary scores, utilizing norm-based scoring based on a general population sample (mean of 50 and standard deviation of 10). All scores are rated so that higher values indicate higher levels of perceived functioning (range, 0-100). The SF-36 has been previously validated in studies with SSc patients (39, 40) . In addition, the modified Health Assessment Questionnaire Disability Index (HAQ) was used for assessing functional status of the patients (41) . Questions were graded from 0 to 3, based on selfperceived ability to "perform in a normal manner" to being "unable to perform." The higher HAQ score indicated more physical disability.
Similar to our previous study (24) , all psychosocial instruments demonstrated adequate internal consistency reliability. Social support measured by the ISEL questionnaire had the Cronbach's alpha of 0.87. IBQ and AHI showed the Cronbach's alphas of 0.85 and 0.70. SF-36 had the Cronbach's alphas of 0.91 and 0.88 for PCS and MCS, respectively. The Cronbach's alphas of HAQ and fatigue scores were also adequate at 0.91 and 0.90, respectively.
Statistical Analysis
Patients who were homemakers, retired, or unemployed for reasons other than health problems at baseline (group C) were excluded from analysis (n ϭ 29). In the crosssectional analysis, we examined the association of the independent variables with disability status at the baseline visit (group A vs group B). The univariate analysis was conducted with Student's t-tests for continuous and the 2 test for categorical variables. We next conducted a hierarchical modeling with successive conceptual blocks to evaluate our hypothesis that demographic, clinical, and psychosocial variables independently contribute to WD in SSc. The independent variables with a P Ͻ 0.1 in the univariate analysis were added into the analysis in the following successive conceptual blocks: demographic information, clinical manifestations, self-reported clinical outcomes (pain and dyspnea), and psychosocial variables. The model fit was assessed after addition of each block by using Bayesian Information Criterion (BIC). Lower BIC values indicate a better model fit. BIC values are interpreted as weak evidence for better fit with a difference of 0 to 2, positive evidence with a difference of 2 to 6, strong evidence with a difference of 6 to 10, and very strong evidence for better fit with a difference of Ͼ10. This approach tested the proposition that each conceptual block contributes independently to WD and is not merely a mediator of previous variables. HAQ is a direct measure of disability (41) and can mediate the effect of other factors on WD. In addition, SF-36 PCS as a measure of overall perceived physical health has overlap with clinical and patient-reported clinical outcomes and it might be partially an effect mediator of the clinical domain. Therefore, we exclude HAQ and SF-36 PCS in the blockwise hierarchical modeling and final multivariate models.
The final multivariate model at the cross-sectional level was computed utilizing a forward hierarchical variable selection strategy. This approach was chosen to decrease the effect of multi-colinearity in our analysis. We initially entered all variables that showed an association with P Ͻ 0.1 in the univariate analysis. Subsequently, the number of independent variables was reduced to those variables that changed the R 2 of the entire model by 1%. We did not include income level and medical insurance as independent variables in our models because they were a consequence rather than a risk factor for WD.
We next included all patients who were working or full-time students at enrollment (group A) in the longitudinal study. For this component, time to event (occurrence of disability) analysis was conducted utilizing a Cox proportional hazards regression model. The date of enrollment into the study was used as the starting point. An initial univariate analysis examining the relationship of independent variables with occurrence of disability after enrollment was conducted. The final multivariate model was computed using the hierarchical forward variable selection strategy as described above. All the statistical analyses were performed with NCSS 2007 (NCSS, Kaysville, UT) and STATA 11 (StataCorp, College Station, TX). The hypothesis testing was 2-sided with a P Յ 0.05 significance level.
RESULTS

Population Characteristics and Prevalence of WD at Baseline Visit
All 284 patients in the GENISOS were included in the study. Patients were followed for a mean (ϮSD) time of 3.9 (3.6), up to 12 years, in 1438 visits. The mean age of patients at enrollment was 48.7 (Ϯ13.2) years and 237 (83.5%) of the cohort were female. The patients were from the following ethnic groups: 133 (46.8%) white, 83 (28.9%) Hispanic, 58 (20.4%) African American, and 10 (3.5%) from other ethnic backgrounds. Diffuse skin involvement was reported in 162 (57.0%) patients. Average disease duration at enrollment was 2.5 (Ϯ1.6) years (Table 1).
At enrollment, 131 patients (46.1%) were in group A, including 111 (39.1%) full-time workers, 14 (4.9%) working part-time for reasons other than health problems, and 6 full-time students (Fig. 1) . Group B (n ϭ 124; 43.7%) consisted of 83 (29.2%) patients self-reported as work disabled and 41 (14.3%) part-time workers, unemployed, or retired earlier due to health problems. The remainder of patients were in group C (n ϭ 29, 10.2%). We included the patients in group A (working at baseline) for longitudinal study. Of 131 patient, 96 (73.3%) were still working, while 35 (26.7%) became disabled after 4.4 (Ϯ3.8) years of follow-up, in 740 visits (Fig. 1) .
Univariate Analysis of WD Correlates at Baseline Visit
In the univariate analysis, the following demographic variables were associated with WD: older age, non-white ethnicity, being single, separated, or divorced, lower educational background (holding high school diploma or lower degrees), while there was no association with gender.
Among clinical manifestations, cardiac involvement, lung disease (FVC and DLCO % predicted values), small joint contracture, number of comorbid conditions, and Medsger Gastrointestinal Tract and Lung Severity Indices were significant correlates of WD. However, disease duration, MRSS, digital ulcers, gastrointestinal symptoms like dysphagia and diarrhea, body mass index, abnormal renal function, arthritis, large joint contracture, myositis, elevated creatinine kinase, and serologic findings were not associated with WD. Moreover, recent treatment with corticosteroid and/or records of cyclophosphamide therapy did not correlate with WD (Table 2 and Supplement 1). Patient-reported clinical outcomes, VAS pain and shortness of breath, were both significantly higher in those with WD.
Patients with WD had more maladaptive illness behavior (higher IBQ score), more fatigue (higher score on Fatigue Severity Scale), higher learned helplessness (higher score on AHI), and HAQ scores. Furthermore, they reported less interpersonal support (lower ISEL score) and health-related quality of life (lower SF-36 -mental and physical components) ( Table 2 and supplement 1).
Independent Correlates of WD at Enrollment-Successive Conceptual Blocks
To determine the independent correlates of WD in the patients with SSc, we successively added the following conceptual blocks into the multivariate multiple: (1) different demographic; (2) clinical manifestations; (3) patient-reported clinical outcome; and (4) psychosocial variables into conceptual blocks. The demographic characteristics (Table 3 , model 1) provided the BIC of 330 (P Ͻ 0.001 for model 1). In model 2, we added the clinical manifestations to demographic variables resulting in an improved BIC of 303, which demonstrated a strong evidence for better model fit (delta ϭ 27, P Ͻ 0.001 for model 2). In model 3, the patients reported clinical outcomes (pain and dyspnea) were added to the previous 2 blocks. Model 3 had a BIC value of 295, which is consistent with positive evidence for better model fit to the observed data (delta ϭ 8, P Ͻ 0.001 for model 3).
In model 4, the psychosocial factors were added to the demographic and clinical manifestation blocks. Model 4 had the lowest BIC (290) and showed strong evidence for a better model fit compared with model 2 (delta ϭ 13) and positive evidence for better model fit to model 3 (delta ϭ 5). This blockwise hierarchical modeling strategy indicated that each successive block contributed independently to WD and was not merely a mediator of previous blocks, while it cannot be ruled out that the successive models (e.g., patient-reported clinical outcomes or psychosocial factors) are partially effect mediators of previous conceptual blocks.
Independent Correlates of WD at Enrollment-Final Model
All relevant demographic, clinical, and psychosocial variables were included in the final model ( Table 4) . The forward hierarchical model showed that educational level below an associate's degree (P Ͻ 0.001), higher Medsger Lung Severity Index (P ϭ 0.004), higher Fatigue Severity Score (P Ͻ 0.001), and less social support (P Ͻ 0.001) were independently associated with WD, at baseline. For example, those patients who had an associate's degree or above were 78% less likely to be WD at the baseline visit, while with each unit decrease in the ISEL score (less social support), the patients were 2.1 times more likely to be WD.
Univariate Predictors of WD on Follow-Up Visits
We next examined predictors of developing WD in patients belonging to group A (Fig. 1) . Small joint contractures (P ϭ 0.001), lower DLCO % predicted value (P ϭ 0.017), and Medsger's Lung Severity Index (P ϭ 0.049) at enrollment were the significant clinical predictors of long-term WD. Furthermore, all 6 psychosocial measures were significant predictors of WD in the Cox regression univariate analysis. Higher IBQ, learned helplessness, FSS, and HAQ scores (P ϭ 0.001, P ϭ 0.041, P ϭ 0.006, P ϭ 0.002, respectively), and lower ISEL, SF-36 PCS, and MCS scores (P ϭ 0.014, P ϭ 0.002, and P ϭ 0.041) were predictors of WD. However, serologic findings, MRSS, abnormal renal function, cardiac involvement, number of comorbid conditions, and history of treatment with corticosteroid or cyclophosphamide did not influence long term the WD (Supplement 2).
Independent Predictors of WD in the Multivariate Model
In the multivariate model following a forward hierarchical variable selection strategy, non-white ethnicity (P ϭ 0.038), lower DLCO (P ϭ 0.038), and higher score on Fatigue Severity Scale (P ϭ 0.009) at baseline were the only independent predictors of WD on follow-up visits (Table 5) . Caucasians had 54% less chance of becoming work disabled compared with non-Caucasians (P ϭ 0.038). Similarly, patients with higher DLCO% predicted at the baseline visit were less likely to develop WD on follow-up visits. Moreover, for each point increase in FSS score at the baseline visit, the patient had 96% higher risk of developing WD (P ϭ 0.009). This final model supports our initial hypothesis that demographic, clinical, and psychosocial factors contribute to WD in SSc. 
DISCUSSION
Professional life plays a crucial role in patients' overall quality of life. Herein, we demonstrate that demographic, clinical, and psychosocial factors contribute to SSc-WD. To our knowledge, this is the first report on impact of SSc on the employment status in the United States. Moreover, it is the first longitudinal study examining the predictors of WD in patients with early SSc. In addition to comprehensive demographic and clinical data, we also investigated the cross-sectional and longitudinal influence of social support (ISEL), learned helplessness (AHI), coping skills (IBQ), and other previously reported psychometric correlates of WD in SSc (fatigue, HAQ, and SF-36) (7) (8) (9) (10) (11) 21) . We hypothesized that demographic, clinical, patient-reported outcomes, and psychosocial factors determine the occupational status in an individual with SSc.
Confirming previous studies (7-11), we showed a high prevalence of WD in early SSc (43.7%). However, the observed prevalence was higher than reports from the well-characterized Canadian Scleroderma Registry Group (46% vs 21%) (7) . This discrepancy could be explained by differences in the investigated study populations. Our patients had a higher frequency of diffuse cutaneous involvement (57% vs 48%). Furthermore, GENISOS was an inception cohort with mean disease duration of 2.5 years at enrollment, which is more likely to include patients with severe disease than a prevalent cohort. More- over, the majority of the study population was white (90%) in the Canadian Scleroderma Registry, whereas GENISOS included 53% non-white patients; non-Caucasians had a higher mortality rate (3) and were more likely to be disabled (Table 2) . On the other hand, the prevalence of WD in GENISOS was lower than another study of 72 SSc patients in France (8) . The same group later reported a WD prevalence of 41% among patients with digital ulcers (9) . Differing health care policies of the investigated countries might also contribute to the observed variations in prevalence rate of WD (16) . Nevertheless, the prevalence of WD in SSc is substantially higher than other common rheumatic conditions (10, (16) (17) (18) (19) (20) .
In agreement with previous studies, demographic variables, specifically, lower educational level (7, 11) , lung involvement (9,11), fatigue severity (7, 11) , and social support, were independent correlates of WD at the cross-sectional level in our study. Patients with lower educational level are more likely to hold occupations that are physically demanding. Therefore, its correlation with WD is not surprising. Similar demographic variables were correlates of WD in patients with early RA (42) and SLE (43) . Fatigue also correlated with WD in previous studies of patients with SSc (21) .
Confirming a recent report by Sandqvist and coworkers, social support was an independent correlate of WD in the GENISOS cohort (21) . Previous studies have shown the impact of social support on disease activity, self-perceived quality of life, and occupational status in the patients with SLE (17, 44, 45) . Furthermore, a national longitudinal study of the overall population in the United States demonstrated that social support is an independent predictor of overall functional health (46) . These further emphasize on the pivotal role of high-quality social relationships with family and friends on the patient's work ability. Because of its modifiable nature, the independent correlation between social support and WD suggests the necessity of multifaceted psychosocial interventions to enhance the working abilities among the patients with SSc.
After a follow-up of 4.4 years, more than 25% of working at enrollment (group A) became work disabled. Using Cox proportional hazards regression model, non-white ethnicity, lung involvement (DLCO % predicted), and higher score on Fatigue Severity Scale at baseline were the independent predictors of WD in the longitudinal study.
We have previously shown that non-white patients have higher mortality in the GENISOS cohort (3), indicating an overall less favorable prognosis (3, 47, 48) . The predictive significance of non-white ethnicity for development of WD might be secondary to unmeasured demographic, clinical, and psychosocial factors. Health care factors leading to disparities in access to care might also be important (49) . Non-white ethnicity was also predictive of WD development in other rheumatic diseases like SLE (50) .
Scleroderma pulmonary involvement, including both interstitial lung disease and pulmonary arterial hypertension, is the primary cause of SSc-related death (51). Confirming previous results, we have shown that pulmonary involvement is also a predictor of mortality in the GENISOS cohort (3) . Therefore, it is not surprising that pulmonary involvement was associated with WD at baseline and longitudinally in the current study.
In the Scleroderma Lung Study, treatment with oral cyclophosphamide led to improvement in health-related quality-of-life measures along with better pulmonary function (52) . In the current study, treatment with cyclophosphamide had no significant relationship to WD. However, differences in baseline characteristics between treated and untreated groups might have blunted the treatment effect. Randomized controlled studies with long-term follow-up are more appropriate to determine the effect of various medications on WD.
Fatigue is one of the most common and overlooked complaints in patients with SSc (53). Our results confirm previous cross-sectional studies indicating that fatigue is an important contributor to WD (21, 53, 54) . In our study, fatigue was not only a correlate (cross-sectional) but also a predictor (longitudinal) of WD. Fatigue might be partially a mediator of the effects of demographic and clinical factors on WD. However, our analysis with successive conceptual blocks demonstrates that psychosocial factors including fatigue contribute independently to WD and are not merely mediators of demographic or clinical factors. Our findings further underscore the need for future studies focusing on pathophysiology and treatment of fatigue in SSc.
In agreement with a previous study (21) , small joint contracture was associated with WD at the univariate level. However, it was neither an independent correlate nor a predictor of WD in the multivariate model. It is possible that a dichotomized variable as defined in our cohort does not capture the true severity of small joint contracture.
The GENISOS cohort includes a large number of early SSc patients from different ethnic backgrounds. The current study demonstrates the first assessment of prevalence, correlates, and predictors of WD in SSc that includes a sizable Hispanic and African-American population. This enhances the generalizability of our findings. Furthermore, the comprehensive array of demographic, clinical, and psychosocial variables decreases the likelihood of missing important correlates or predictors.
However, the current study had some limitations. The majority of study subjects were recruited from tertiary medical centers, which can introduce referral bias (toward more severe cases). Detailed information on job descriptions and demands was not available in the GENISOS cohort. Therefore, we could not evaluate the impact of job demands on WD. Moreover, we could not examine change in the professional level, i.e., downgrading to another job due to SSc in the current study. We did not use a validated psychometric instrument to assess depression in the GENISOS cohort. However, other psychometric instruments for assessment of mental health such as SF-36 MCS were utilized in the current study.
In conclusion, WD is a prominent problem in patients with SSc. More than 40% of patients were already work disabled at early stages of the disease. After 4.4 years, more than one fourth of those working at enrollment eventually became work disabled. WD is a function of demographic background, clinical and psychosocial factors, cross-sectionally and longitudinally. These findings underscore the need for a multidisciplinary approach to treatment of SSc patients.
